Abbott Laboratories (ABT)

$135.01 0.82 (0.60%)

9:54 EST ABT Stock Quote Delayed 30 Minutes

7 Tremendous Dividend Stocks With Double-Digit 5-Year Growth Rates

By Rich Duprey, InvestorPlace Contributor Feb 7, 2024

When it comes to buying dividend stocks, investors should seek out companies that consistently and reliably grow their payout over time.

7 ‘AgeTech’ Stocks to Profit From the Booming Longevity Market

7 Safe-Haven Stocks to Protect Your Portfolio During a Recession

Silver Economy Successes: 3 Stocks Benefitting From an Aging Population

Volume:

Previous Close -

Market Cap 236.39B

PE Ratio 17.67

EPS 7.64

Volume (Avg. Vol.) 600,091

Day's Range $134.27 - $135.85

52-Week Range $99.71 - $136.59

Dividend & Yield $2.20 (1.63%)

ABT Stock Predictions, Articles, and Abbott Laboratories News

3 Dividend Kings to Buy for Royal Returns

By Faizan Farooque, InvestorPlace Contributor Nov 6, 2023

Unlock the secrets of dividend kings, the aristocrats of the stock market with unparalleled records of raising dividends yearly.

7 Blue-Chip Stocks to Buy on the Dip

By Josh Enomoto, InvestorPlace Contributor Oct 19, 2023

While you can find plenty of ideas swimming in red ink, investors may find greater success with blue-chip stocks to buy on the dip.

September Rally? 3 Healthcare Stocks to Buy Before Liftoff.

By Chris Markoch, InvestorPlace Contributor Sep 8, 2023

The anticipated volume of future healthcare spending makes this a time to look at healthcare stocks to buy for the long term.

The 3 Best Pharma Stocks to Buy Now: September 2023

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor Sep 8, 2023

There are pharma stocks to buy for each type of investor. This article explores the best options in the industry.

U.S. Credit Rating Concerns? Here Are 3 Stocks to Protect Your Portfolio

By Rick Orford, InvestorPlace Contributor Aug 24, 2023

Looking for stocks to buy amid the U.S. credit rating downgrade? Look no further. These companies have you covered.

Investing for the Long-Term? Here are 7 Must-Have Dividend Stocks

By Chris Markoch, InvestorPlace Contributor May 14, 2023

Here are seven must-have dividend stocks for long-term investing that you can consider for your dividend stock portfolio

3 Stocks to Buy on the Cusp of a Breakout

By Joel Baglole, InvestorPlace Contributor May 1, 2023

Here are three stocks to buy, for investors looking for companies on the cusp of a potential breakout driven by secular growth catalysts.

7 Healthcare Stocks With Huge Return Potential for Long-Term Investors

By Joel Baglole, InvestorPlace Contributor Apr 27, 2023

Health spending per person in the U.S. was $12,914 in 2021, which was about $5,000 more than any other developed country. All told, the U.S. spends more than $4 trillion each year on healthcare, making it one of the leading sectors of the world's biggest economy.

3 Healthcare Stocks to Watch As the Industry Evolves

By Faizan Farooque, InvestorPlace Contributor Mar 31, 2023

Healthcare stocks are often considered a safe investment due to the consistent demand for medical products and services.

7 Hot Healthcare Stocks With the Potential to Outperform

By Joel Baglole, InvestorPlace Contributor Feb 15, 2023

These healthcare stocks to buy now have the potential to outperform the market over the long-term because their businesses are strong.

Which Healthcare Stock Is a Better Pick in 2023?

By Sirisha Bhogaraju Feb 14, 2023

With a potential recession on the horizon, healthcare stocks could be good picks for investors. Which of these three are best?

7 No-Brainer Blue-Chip Stocks to Buy for 2023 and Beyond

By Josh Enomoto, InvestorPlace Contributor Nov 12, 2022

With so many troubles ailing the economy and the broader market, investors should focus on blue-chip stocks to buy.

3 Stocks Set to Soar From 52-Week Lows

By Alex Sirois, InvestorPlace Contributor Oct 19, 2022

Calling a market bottom is nearly impossible and it isn't likely near but these stocks to buy should be shielded from further declines.

7 Vaccine Stocks to Sell ASAP Now That the ‘Pandemic’s Over’

By Chris Lau, InvestorPlace Contributor Sep 27, 2022

Investors have seven widely-followed vaccine stocks to sell now, after the world decided the pandemic is over.

7 Large-Cap Stocks to Buy on the Dip

By Tezcan Gecgil, InvestorPlace Contributor Jul 27, 2022

Here are seven large-cap stocks to buy on the dip that could offer lucrative returns for long-term investors.

Abbott Laboratories (ABT) Stock Slides Despite Q2 Earnings Beat

By William White, InvestorPlace Writer Jul 20, 2022

Abbott Laboratories (ABT) stock is falling on Wednesday despite posting a positive earnings report for the second quarter of 2022.

7 Monkeypox Stocks That May Take Off in Q2

By Brian Paradza, CFA Jun 9, 2022

SIGA Technologies (SIGA) may lead on the list of monkeypox stocks that could soar, but Bavarian Nordic seems to be leading the sales race.

ABT Stock Climbs as Abbott Reaches a Baby Formula Deal With the FDA

By Joel Baglole, InvestorPlace Contributor May 17, 2022

ABT stock is climbing on reports that Abbott has reached a deal to restart baby formula production at its Sturgis, Michigan plant.

7 Stocks to Buy If You Think Inflation Is Topping Out

By Chris Markoch, InvestorPlace Contributor Apr 22, 2022

Some analysts believe that the market may have seen peak inflation. Here are seven stocks to buy if inflation is at, or near, its peak

7 Long-Term Stocks to Buy Now and Hold Forever

By Chris MacDonald, InvestorPlace Contributor Mar 3, 2022

Here are seven long-term stocks that fit well in most investors' portfolios as core holdings over decades, at least historically speaking.

Abbott Laboratories (ABT)

7 Tremendous Dividend Stocks With Double-Digit 5-Year Growth Rates

7 ‘AgeTech’ Stocks to Profit From the Booming Longevity Market

7 Safe-Haven Stocks to Protect Your Portfolio During a Recession

Silver Economy Successes: 3 Stocks Benefitting From an Aging Population

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

Abbott Laboratories (ABT)

Louis Navellier's Total Grade

Is ? a BUY?

Louis Navellier's Total Grade

Louis Navellier's Total Grade

Fundamental Grade

Quantitative Grade

ABT Stock Predictions, Articles, and Abbott Laboratories News

Subscriber Sign in